Target(s)
- Pfizer Inc
Summary
Johnson & Johnson - proposed acquisition of Pfizer Inc's consumer healthcare businessMarket definition
The proposed acquisition was considered in relation to the supply in Australia of:1. worm treatments;
2. anti-diarrhoeals; and
2. nicotine replacement therapy products.
Competition analysis
The ACCC decided not to oppose the proposed acquisition subject to section 87B undertakings being provided by Johnson & Johnson and Pfizer Inc. The reasons for the ACCC's decision are set out in the Public Competition Assessment relating to this matter.Statement of issues
Public competition assessment
Undertakings
Timeline
| Date | Event |
|---|---|
| 04/10/2006 | ACCC received submission from Johnson & Johnson. ACCC commences review under the Merger Review Process Guidelines. Market inquiries commence. |
| 11/10/2006 | ACCC requested further information from Johnson & Johnson. Indicative timeline suspended pending receipt of Johnson & Johnson's response. |
| 16/10/2006 | ACCC received Johnson & Johnson's response to ACCC information request of 11 October. |
| 18/10/2006 | Johnson & Johnson advised intention to make submission to ACCC addressing possible competition effects. |
| 20/10/2006 | Closing date for submissions from interested parties. |
| 01/11/2006 | ACCC received submission from Johnson & Johnson addressing possible competition effects. |
| 06/11/2006 | Proposed date for announcement of ACCC's findings (30 November 2006) delayed pending the resolution of Applicant's claim for confidentiality and related matters. |
| 24/11/2006 | Applicant's claim for confidentiality and related matters resolved. ACCC timeline recommenced. |
| 28/11/2006 | ACCC published Statement of Issues outlining its preliminary competition concerns. |
| 11/12/2006 | Closing date for submissions from interested parties responding to ACCC's Statement of Issues. |
| 13/12/2006 | Johnson & Johnson submitted s.87B Undertaking relating to its divestiture proposal for market inquiries by ACCC, and ACCC commenced market inquiries on Johnson & Johnson's proposed divestiture. |
| 15/12/2006 | Closing date for submissions from interested parties regarding Johnson & Johnson's proposed divestiture. |
| 21/12/2006 | ACCC accepted section 87B undertakings from Johnson & Johnson and Pfizer and announced it will not oppose the proposed acquisition. |